Skip to main content

Table 1 Patient characteristics and outcomes of Campylobacter and Helicobacter bacteremia

From: Comparison of the clinical and microbiological characteristics of Campylobacter and Helicobacter bacteremia: the importance of time to blood culture positivity using the BACTEC blood culture systems

 

Helicobacter spp.

Campylobacter spp.

N

16

14

Age (years), mean ± SD

61 ± 18

49 ± 21

Sex (male)

10

8

Hospital-acquired infection*

7 (43.8%)

1 (7.1%)

Animal contact

3 (18.8%)

1 (7.1%)

Underlying diseases

16 (100%)

10 (71.4%)

Solid organ cancer

8

4

Hematological malignancy

4

1

Liver cirrhosis

4

2

Collagen vascular disease

2

1

Others

2

5

Side effects of immunosuppressants (including chemotherapy for cancer)*

8 (50%)

1 (7.1%)

Clinical manifestations

 Fever (> 37.5 °C)

11

13

 Diarrhea

0

7

 Skin lesion*

8

1

 Arthralgia

0

3

 Headache

2

3

 Others

2

5

 No apparent symptom

5

1

 *Body temperature (°C), mean ± SD

38.1 ± 1.0

38.8 ± 0.9

Treatment

 No antibiotics

1

1

 Penicillin

11

2

 Cephalosporin

9

7

 β-lactamase/β-lactam

4

4

 Carbapenem

5

3

 Macrolide

2

2

 Fluoroquinolone

2

3

 Doxycycline/minocycline

12

2

 Others

0

1

 Total duration of antibiotic treatment (days),mean ± SD

36 ± 26

10 ± 8

Persistent bacteremia (> 48 h)

2

0

Recurrent case

3

0

  1. p value < 0.05,  p value < 0.01